diversity

Patients

The case for adaptive EDI strategies in the UK

Clinical research in the UK is on a mission to ensure everyone, regardless of who they are, can participate.

Patients

Operationalising diversity through site and patient engageme...

Most sponsors are aware of the benefits that may arise from increasing the diversity of clinical trial patient populations.

R&D

On a journey to diverse, inclusive, and more efficient rare ...

Although orphan drugs represent a sizeable portion of new drug approvals,1most rare diseases still lack effective treatment.

News

Gilead plans European trial of twice-yearly HIV PrEP drug

Gilead Sciences has said it will soon start a clinical trial in Europe of its twice-yearly HIV injection Sunlenca for pre-exposure prophylaxis (PrEP), a potential successo

Market Access

Why the key to success lies in leadership diversity

Before moving into healthcare, I began my career as a nuclear physicist in Romania. At the time, there were not many women working in this field.

News

CVS retreats from the clinical trial business

CVS Health has decided to shut down its clinical trials business, just two years after launching it to great fanfare in the midst of the COVID-19 pandemic.